SSA
BIVI icon

Schonfeld Strategic Advisors’s BioVie BIVI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-139
Closed -$47.4K – 1877
2023
Q3 		$47.4K Sell
139
-43
-24% -$16.8K ﹤0.01% 1539
2023
Q2 		$78.4K Buy
182
+25
+16% +$16.8K ﹤0.01% 1760
2023
Q1 		$127K Buy
157
+2
+1% +$1.33K ﹤0.01% 1646
2022
Q4 		$120K Buy
+155
New +$83.8K ﹤0.01% 2134

Other funds holding BIVI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Schonfeld Strategic Advisors's BIVI Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of BioVie (BIVI) in Q4 2023, closing a stake of 139 shares — an estimated $47.4K sold.

Schonfeld Strategic Advisors first reported a position in BIVI in Q4 2022 and held it in 4 quarters. The position peaked at $127K in Q1 2023. 53 funds tracked by Wall St. Rank hold BIVI as of Q4 2023.

  • Schonfeld Strategic Advisors reported no remaining BioVie position as of Q4 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 139 BioVie shares in Q4 2023, an estimated $47.4K.
  • Schonfeld Strategic Advisors first reported a position in BioVie in Q4 2022 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's BioVie position peaked at $127K in Q1 2023.
  • 53 funds tracked by Wall St. Rank held BioVie as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.